Mercer Global Advisors
ANIX icon

Mercer Global Advisors’s Anixa Biosciences ANIX Stock Holding History

Mercer Global Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8K Buy
+1,000
New +$2.78K ﹤0.01% 5510

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mercer Global Advisors's ANIX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Anixa Biosciences (ANIX) in Q2 2026: 1,000 shares worth $2.8K. The stake represents ﹤0.01% of the portfolio and ranks #5510 among its holdings.

48 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Mercer Global Advisors held 1,000 shares of Anixa Biosciences worth $2.8K as of Q2 2026.
  • Anixa Biosciences was a new Mercer Global Advisors position in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5510 holding.
  • 48 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.